Among patients with moderate to severe atopic dermatitis, APG777 produced significant reductions in disease severity at 16 weeks.

Black patients with CSU have greater rates of angioedema, IgE levels, quality of life impairment, and BMI than White or Asian patients.

Daily application of roflumilast cream for 52 weeks improves the signs and symptoms of AD in patients with various comorbid atopic conditions.

Improvements in urticaria control and quality of life among patients with chronic inducible urticaria were observed with 20 weeks of barzolvolimab.

Among patients with PUPPP, 52.3% had atopy history, whereas 47.1% of matched control patients without PUPPP had atopy history.

AAAAI President Carla Davis, MD, outlined 3 key initiatives involving AI, advocacy, and research at the 2026 AAAAI conference.

In October, the U.S. Centers for Disease Control and Prevention changed its guidance, recommending COVID vaccines only for adults 65 and older after consulting a doctor or pharmacist. Before that, the ...

Umeclidinium-vilanterol is associated with improved clinical outcomes in symptomatic patients with chronic obstructive pulmonary disease.

A group of 15 states is suing the Trump administration over recent changes to federal vaccine guidelines for kids.